Cosmo gets U.S. approval for agent aimed at easing polyp removal

ZURICH (Reuters) - Cosmo Pharmaceuticals SA said on Friday that the U.S. Food and Drug Administration has given marketing authorization for SIC 8000, a product used in gastrointestinal tract procedures.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news